Blackwell named to Time most influential people list
http://youtu.be/3IMz2DoPJro
Kimberly Blackwell, MD, professor of medicine (Medical Oncology) and clinical oncologist at the Duke Cancer Institute, is included in this year's roster of TIME magazine's 100 most influential people.
Dr. Blackwell is director of the breast cancer program at Duke Cancer Institute.
Abernethy, Payne to speak at TEDMED this week
The School of Medicine is hosting a TEDMED simulcast April 16-19 in the Mary Duke Biddle Trent Semans Center for Health Education on the 4th Floor in the Student Affairs Living Room.
TEDMED is an annual event that features a multi-disciplinary community of innovators and leaders in health and medicine.
Among the TEDMED speakers this year are two Duke Deparement of Medicine faculty members: Amy Abernethy, MD, and
Outpatient palliative care program in local news
Duke Center for Palliative Care's new outpatient palliative care program was recently featured in The News & Observer and on WRAL.
[quote style="boxed"]One of the really important characteristics of palliative care is that you don't have to reject curative care.
Grand Rounds 4/12/13: Prostate Cancer
Medicine Grand Rounds on Fri., April 12 at 8 a.m. in Duke Hospital room 2002 will feature Steven Patierno, PhD, professor of medicine and deputy director of Duke Cancer Institute; William Lee, MD, professor of radiation oncology and associate professor of surgery; Daniel George, MD, associate professor of medicine (Medical Oncology) and surgery; and Stephen Freedland, MD, associate professor of pathology and surgery.
Dr. Patierno, Dr. Lee, Dr. George and Dr.
Research Conference 2/22/13: Biomarkers, preclinical modeling in colorectal cancer
The Medicine Research Conference returns Fri., Feb. 22 at 12 p.m. in Duke Hospital 2002 with a presentation by David Hsu, MD, PhD, assistant professor of medicine (Medical Oncology) and William Dalton Family Assistant Professor of Cancer Genomics.
Dr.
Abernethy speaks about the treasures of patient data
Amy Abernethy, MD, associate professor of medicine (Medical Oncology) and director of the Duke Cancer Care Research Program, was a featured speaker at ScienceOnline2013 on Feb. 2.
MRRC News: Patient Navigation Conference, UNC Zollicoffer-Merrimon Lecture
The Minority Recruitment and Retention Committee invites Department of Medicine faculty and staff to attend several upcoming events:
The North Carolina Oncology Navigator Association will hold a Patient Navigation Conference from 10 a.m.-2 p.m. Fri., Feb. 1 in the Searle Center.
Two Duke researchers receive awards from Ovarian Cancer Research Fund
The Ovarian Cancer Research Fund has awarded two Duke researchers grants through the Liz Tilberis Scholars Program, which supports junior faculty with a strong commitment to ovarian cancer research.
Mythreye Karthikeyan, PhD, assistant professor of medicine (Medical Oncology), was awarded $450,000 for a period of three years for the project "Investigating the TGFß Superfamily as Therapeutic Targets in Ovarian Cancer."
Dr.